Moderna, Inc. (MRNA)
138.82
-6.31
(-4.35%)
USD |
NASDAQ |
Aug 24, 16:00
139.00
+0.18
(+0.13%)
After-Hours: 20:00
Moderna Total Liabilities (Quarterly) : 4.20B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.20B |
| March 31, 2026 | 4.08B |
| December 31, 2025 | 3.688B |
| September 30, 2025 | 2.805B |
| June 30, 2025 | 2.611B |
| March 31, 2025 | 2.638B |
| December 31, 2024 | 3.241B |
| September 30, 2024 | 3.876B |
| June 30, 2024 | 3.968B |
| March 31, 2024 | 3.912B |
| December 31, 2023 | 4.572B |
| September 30, 2023 | 5.995B |
| June 30, 2023 | 4.935B |
| March 31, 2023 | 5.262B |
| December 31, 2022 | 6.964B |
| September 30, 2022 | 8.064B |
| June 30, 2022 | 8.058B |
| March 31, 2022 | 10.53B |
| Date | Value |
|---|---|
| December 31, 2021 | 10.72B |
| September 30, 2021 | 10.80B |
| June 30, 2021 | 9.449B |
| March 31, 2021 | 8.856B |
| December 31, 2020 | 4.775B |
| September 30, 2020 | 1.891B |
| June 30, 2020 | 539.12M |
| March 31, 2020 | 426.67M |
| December 31, 2019 | 414.61M |
| September 30, 2019 | 339.09M |
| June 30, 2019 | 346.72M |
| March 31, 2019 | 360.17M |
| December 31, 2018 | 431.91M |
| September 30, 2018 | 412.73M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 459.19M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioNTech SE | 2.956B |
| Kailera Therapeutics, Inc. | 92.95M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Replimune Group, Inc. | 146.80M |
| Intellia Therapeutics, Inc. | 129.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.96B |
| Shareholders Equity (Quarterly) | 6.761B |
| Debt to Equity Ratio | 0.1904 |
| Current Ratio | 2.295 |
| Net Debt Paydown Yield | -0.39% |